Allergan enlists Exicure in search of hair loss drugs with $25M upfront, doubling down on area dear to AbbVie

After AbbVie became a formidable player in medical aesthetics overnight by swallowing Allergan, the Botox maker is beefing up the pipeline with new R&D projects.